Best Picks,His-{Aib}-Gln-Gly-Thr-Phe-Thr-Ser-Asp-Tyr-Ser-Lys-Tyr-Leu-Asp-Glu

The intricate world of peptide therapeutics is constantly evolving, and Mazdutide stands as a testament to this progress. This novel compound, also known by its developmental code IBI362 and LY3305677, has garnered significant attention as a dual agonist of the GLP-1 receptor and glucagon receptor (GCGR). Understanding the mazdutide sequence is fundamental to appreciating its mechanism of action and therapeutic potential in conditions such as obesity and type 2 diabetes.

At its core, Mazdutide is a long-acting synthetic analog of the gut peptide hormone oxyntomodulin. Its sequence is meticulously designed to optimize the activation of both the GLP-1 receptor and the GCGR. The optimized peptide sequence design allows Mazdutide to effectively engage these critical metabolic pathways. While specific comprehensive sequence details can sometimes be listed as Sequences: Not Available in certain databases, the available information provides a clear insight into its peptide nature.

The mazdutide sequence begins with His-{Aib}-Gln-Gly-Thr-Phe-Thr-Ser-Asp-Tyr-Ser-Lys-Tyr-Leu-Asp-Glu. This specific arrangement of amino acids, including the non-natural amino acid Aib (alpha-aminoisobutyric acid), contributes to its stability and prolonged activity. The presence of Aib is a common strategy in peptide drug design to enhance resistance to enzymatic degradation. Further details of the mazdutide sequence can be found in various chemical databases, with some providing partial or complete listings. For instance, one notable partial sequence is H-His-{Aib}-Gln-Gly-Thr-Phe-Thr-Ser-Asp-Tyr-Ser-Lys-Tyr-Leu-Asp-Glu. Another representation of the mazdutide sequence includes His}{Aib}{Gln}{Gly}{Thr}{Phe}{Thr}{Ser}{Asp}. The complete amino acid sequence of glucagon (GCG) serves as a foundational element, with Mazdutide incorporating additional amino acids to achieve its dual agonist profile.

The molecular weight of Mazdutide is approximately 4476 g/mol or 4563.06 g/mol, depending on the specific form and calculation. Its molecular formula is often cited as C207H317N45O65 or C210H322N46O67. These figures underscore its complex peptide structure. The compound typically appears as a white to off-white solid.

The dual agonism of Mazdutide is central to its therapeutic promise. Activation of the GLP-1 receptor mediates glucose-dependent insulin secretion and promotes satiety, contributing to improved glycemic control and weight loss. Simultaneously, activation of the glucagon receptor (GCGR) plays a role in energy expenditure and glucose homeostasis. By balancing the activation of these two receptors through its specific amino acid sequences, Mazdutide offers a unique mechanism that enhances weight-loss efficacy. This makes Mazdutide a significant development in the field, with Mazdutide being recognized as the world's first dual GCG/GLP-1 receptor agonist approved for weight loss, offering a unique mechanism that enhances weight-loss efficacy.

In research and development, Mazdutide (IBI-362; LY-3305677) has been investigated for its potential in treating obesity and type 2 diabetes (T2D). Clinical trials have explored its efficacy and safety, with promising results emerging. For example, higher doses of Mazdutide have shown differentiated benefits in significantly reducing liver fat content (LFC) and uric acid levels, highlighting its innovative mechanism of action.

For those seeking to obtain this compound for research purposes, Mazdutide buy online options are available through various chemical suppliers, often listed under different catalog numbers such as AG-CP3-0045. The purity of these research-grade compounds is typically ≥98%.

In summary, the mazdutide sequence is the key to its function as an emerging dual GLP-1 and glucagon receptor agonist. This carefully crafted peptide structure, characterized by its unique amino acid arrangement and modification, positions Mazdutide as a significant therapeutic agent for metabolic disorders. Further research into its mazdutide sequence function and Mazdutide structure will continue to illuminate its full potential.